Ignite Creation Date:
2024-05-06 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05130866
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2021-11-10
Brief Title:
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 NF2 Mutated Meningiomas
Sponsor:
Organization:
Recursion Pharmaceuticals Inc